DPP-4 Inhibitor in Type 2 Diabetes Mellitus Patient with Non-Alcoholic Fatty Liver Disease: Achieving Two Goals at Once?
Main Author: | Ji Cheol Bae |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Endocrine Society
2022-12-01
|
Series: | Endocrinology and Metabolism |
Online Access: | http://www.e-enm.org/upload/pdf/enm-2022-605.pdf |
Similar Items
-
The Frequency of Non-Alcoholic Fatty Liver Disease in Adults with Diabetes Mellitus
by: Raheel Akhtar Yousafzai, et al.
Published: (2023-08-01) -
Efficacious and safe management of type 2 diabetes mellitus using DPP-4 inhibitors
by: Alexander Sergeevich Ametov, et al.
Published: (2010-06-01) -
Results and prospects for the use of DPP-4 inhibitor in patients with diabetes mellitus type 2
by: A. M. Mkrtumian, et al.
Published: (2013-12-01) -
Diabetes and bone. Focus on DPP-4 inhibitors
by: A. Y. Babenko, et al.
Published: (2015-12-01) -
The efficacy of therapy with DPP-4 inhibitors combined with insulin in patients with type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)